Substantial weight gain as dolutegravir is rolled out in Africa

Back to the "HIV and Co-Infections News" list

Study finds women gain more weight; underlines need to watch out for weight-related diseases.

A study analysing data from four African countries found that people living with HIV who switched to a dolutegravir-based antiretroviral regimen had a four-fold increase in average weight gain, compared to the year before the switch.

Read the full story at Aidsmap.

 

Source : Aidsmap

Get involved

Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?

Subscribe

Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.